Biowave Corporation to Present at Windhover Information and Medtech Insight's 'Investment in Innovation' Conference.

BOSTON -- Biowave Corporation will be presenting on Thursday, October 21st at 4:35 pm at Windhover Information and Medtech Insight's Prestigious "Investment In Innovation" Event, taking place October 21-22, 2004 at the Westin Copley Place Hotel in Boston, Massachusetts.

Biowave is a minimally invasive neuromodulation pain therapy company whose major goal is to help physicians manage their patients' pain and reduce or eliminate opioid usage. Biowave has developed a family of patented medical device instruments and percutaneous disposables that deliver an electronic signal into deep body tissue, which blocks the transmission of chronic, acute or post-operative musculoskeletal pain. Multiple clinical studies including double blinded randomized crossover studies have shown that a 20-minute treatment provides patients with an 80% reduction in pain and a significant increase in range of motion which lasts for 24 hours. Biowave is used (1) in a hospital setting to treat patients immediately post-operatively following total joint replacement and other orthopedic surgical procedures, (2) in an orthopedic/sports medicine clinic to treat pre-surgical or non-surgical joint pain and (3) in a pain clinic to treat pre-surgical or non-surgical low back and cervical pain. The Biowave treatment is a first course foundation pain therapy that is delivered percutaneously in a physician setting with long lasting efficacy, no side effects and at a reasonable cost. Clinical results are similar to implantable neuromodulation devices, without the risk and at a fraction of the cost. The company has strategic partnership agreements with major US and Japanese medical device companies.

About Medtech Insight

Medtech Insight's "Investment In Innovation" conferences are considered the premier forum for senior executives in the investment and medical technology community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. Medtech Insight, which was recently acquired by Windhover Information Inc. (www.windhover.com), publisher of IN VIVO: The Business & Medicine Report, Start-UP: Windhover's Review of Emerging Technologies, and IN VIVO EuropeRx, offers a wide variety of products and services for the medical technology executive. In addition to conferences, the company publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, as well as analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the Boston conference or for more information on Medtech Insight, please call Scott Pantel at [phone] or [phone] toll-free in the U.S., e-mail [e-mail], or visit http://www.medtechinsight.com/in3-12.html.